NCT06872736 Wereables for Upper Limb Functionality in Hemiparesis
| NCT ID | NCT06872736 |
| Status | Recruiting |
| Phase | Phase 2, Phase 3 |
| Sponsor | Universidade da Coruña |
| Condition | Unilateral Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-06-07 |
| Primary Completion | 2024-09-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 40 participants in total. It began in 2024-06-07 with a primary completion date of 2024-09-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project is configured as a national interventional study that aims to determine the effectiveness of an intervention strategy using wearable technology, tailored to improve function (WeFun-wearable), on the spontaneous use of the affected upper extremity, activities of daily living and the participation in children with unilateral cerebral palsy.
Eligibility Criteria
Inclusion Criteria: * Confirmed diagnosis of UCP. * Children aged between 3 and 8 years old. * Children rated on levels I to III on the Manual Ability Classification System (MACS). Exclusion Criteria: * Botulinum toxin injection or surgical interventions in the upper limb within 6 months prior to study entry. * Medical complications non-controlled that would interfere with study participation (e.g., not controlled epilepsy). * Predominantly athetoid or dystonia movement patterns. * Insufficient cognitive level to follow instructions, * Non-corrected marked visual impairments. Families can be retired from the study after starting if: * Families don't assist or don't collaborate in the weekly sessions with the reference person. * Wearable activity if presumably lower than expected (few recordings of activity, \<20%). * Families don't provide feedback about daily sessions through the satisfaction system in the app/registration sheet.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06872736 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 8 Years, studying Unilateral Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06872736 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06872736 currently recruiting?
Yes, NCT06872736 is actively recruiting participants. Contact the research team at veronica.robles@udc.es for enrollment information.
Where is the NCT06872736 trial being conducted?
This trial is being conducted at A Coruña, Spain.
Who is sponsoring the NCT06872736 clinical trial?
NCT06872736 is sponsored by Universidade da Coruña. The trial plans to enroll 40 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.